Orcosa

Orcosa is a clinical-stage life science company specializing in the development of next-generation oral drug delivery technologies. The company's proprietary OR-VECT platform creates rapidly disintegrating oral tablets (RDOTs) designed to improve the pharmacokinetic profiles and patient compliance of established therapeutic agents. Orcosa's lead programs focus on providing non-opioid alternatives for pain management and treatments for neurological conditions. By leveraging its technology, the company aims to enhance the safety and efficacy of drugs with known challenges in oral absorption or administration. The leadership team consists of industry veterans with a track record of successful drug development and commercialization.